In addition, the concurrent expression of SLex and α2-6 NeuAc suggests that the glycosyltransferases performing the terminal sialylation compete for the CEA acceptor substrate that was identified as the major glycoprotein modified with SLex after ST3Gal IV transfection in gastric cancer cells. This evidence concerns the gene CEACAM5 and gastric cancer.